Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/12/2026

Omega‑3 Fatty Acids in NAFLD/NASH: Evidence‑Based Recommendations

Guideline Positions

Efficacy Evidence

Appropriate Use of Omega‑3

Alternative Effective Therapies

Fish Oil Dosing for Fatty Liver Disease and Wound Healing

Fatty Liver Disease

  • The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines state that omega-3 fatty acids cannot be recommended to treat non-alcoholic fatty liver (NAFL) or non-alcoholic steatohepatitis (NASH) until further data regarding their efficacy are available, with a Grade 0 recommendation and 100% consensus among experts 5, 6, 7
  • The largest and highest-quality trial found no effect of EPA at doses of 1,800 mg/day and 2,700 mg/day versus placebo on liver enzymes, insulin resistance, inflammatory markers, or liver histology in 243 patients with biopsy-proven NASH 5, 6, 7
  • Other trials showed that 3-4 grams of omega-3 fatty acids improved hepatic fat content but failed to improve NASH histology by clinically meaningful criteria 5, 6, 7
  • Meta-analyses concluded that omega-3 fatty acids may reduce liver fat but are ineffective on histologic findings in NASH patients, which matters more for long-term outcomes like cirrhosis and mortality 5, 6, 7
  • If fish oil is used for fatty liver disease, doses studied ranged from 2-4 grams of EPA+DHA daily, and monitoring of liver enzymes and lipid panels is recommended, as fish oil can paradoxically increase LDL-cholesterol by 5-10% in some patients 5, 6, 7, 8

Wound Healing

  • For wound healing, consider 1-2 grams of EPA+DHA daily, started ideally 4 weeks before elective procedures or as soon as possible for existing wounds, as supported by the wound healing trial's methodology and general cardiovascular health guidelines 8, 9
  • Higher doses (2-4 grams) may provide additional anti-inflammatory benefits but have not been specifically tested for wound healing 8, 9
  • Bleeding risk is not increased at doses up to 4-5 grams daily, even with concurrent antiplatelet or anticoagulant therapy 8, 9

Practical Considerations

  • For a patient with both fatty liver disease and delayed wound healing, prioritize wound healing as the indication and start with 1-2 grams of EPA+DHA daily, monitoring lipid panels at baseline and 8-12 weeks 5, 6, 8, 9
  • If LDL rises significantly, add or optimize statin therapy rather than discontinuing fish oil 8
  • Continue fish oil for at least 4 weeks before any elective procedures to allow lipid mediator profiles to shift toward a more healing-conducive environment 8, 9

REFERENCES

4

Omega-3 Fatty Acids for Dyslipidemia Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

5

Omega-3 Fatty Acid Dosing Recommendations [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026